A Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal Impairment

Clinical trial NCT06639087 · TERMINATED

Trial details

NCT number: NCT06639087
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment Heart Failure

Start date: 2024-09-27
Primary completion: 2025-05-29
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.